Lista de obras -

Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas

artículo científico publicado en 2015

Antiangiogenic therapy of brain tumors: the role of bevacizumab.

artículo científico publicado en 2014

Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds

artículo científico publicado en 2015

Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology).

artículo científico publicado en 2013

Brain metastases: current management and new developments

artículo científico publicado en 2008

Caveolin 1 expression independently predicts shorter survival in oligodendrogliomas

artículo científico publicado en 2009

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.

artículo científico publicado en 2016

Controversies in management of low-grade gliomas in light of new data from clinical trials

artículo científico publicado en 2017

Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016

artículo científico publicado en 2019

Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).

artículo científico publicado en 2017

Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology

artículo científico

Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES)

scientific article published on 01 April 2020

Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016

scientific article published on 25 September 2019

Ependymomas of the adult: molecular biology and treatment

artículo científico publicado en 2008

Ependymomas, neuronal and mixed neuronal-glial tumors, dysembroblastic neuroepithelial tumors, pleomorphic xanthoastrocytomas, and pilocytic astrocytomas

artículo científico publicado en 2012

Epilepsy and brain tumors

artículo científico publicado en 2010

European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma.

artículo científico publicado en 2017

Evaluation of low-grade glioma structural changes after chemotherapy using DTI-based histogram analysis and functional diffusion maps

artículo científico publicado en 2015

Gliomatosis cerebri: a review

artículo científico publicado en 2014

Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination

artículo científico publicado en 2009

Is there a Role for Bevacizumab in Non-Glial Tumors?

artículo científico

Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas.

artículo científico publicado en 2016

Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma.

artículo científico publicado en 2015

Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study.

artículo científico publicado en 2017

Leptomeningeal metastases: a RANO proposal for response criteria.

artículo científico publicado en 2016

Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials

artículo científico publicado en 2014

Liquoral liquid biopsy in neoplastic meningitis enables molecular diagnosis and mutation tracking: a proof of concept.

artículo científico publicado en 2016

MGMT promoter methylation in plasma of glioma patients receiving temozolomide

artículo científico publicado en 2014

Malignant spinal cord compression in cerebral glioblastoma multiforme: a multicenter case series and review of the literature

artículo científico publicado en 2012

Meningeal carcinomatosis underdiagnosis and overestimation: incidence in a large consecutive and unselected population of breast cancer patients

artículo científico publicado en 2015

Meningiomas after cranial radiotherapy for childhood cancer: a single institution experience

artículo científico publicado en 2015

Molecularly based management of gliomas in clinical practice

artículo científico

Neuro-oncology: new insights and advances in treatment

scientific article published on January 2008

Neurologic complications of chemotherapy and other newer and experimental approaches

artículo científico

New developments in the treatment of malignant gliomas

artículo científico publicado en 2007

Pharmacologic therapies for malignant glioma: a guide for clinicians.

artículo científico publicado en 2014

Point/Counterpoint: Is stereotactic radiosurgery needed following resection of brain metastasis?

artículo científico publicado en 2016

Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).

artículo científico publicado en 2015

Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.

artículo científico publicado en 2017

Rare glial tumors

artículo científico publicado en 2016

Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study

artículo científico publicado en 2004

Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study

artículo científico publicado en 2013

Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments

artículo científico

Skin metastases of glioblastoma in the absence of intracranial progression are associated with a shift towards a mesenchymal immunophenotype: report of two cases

artículo científico publicado en 2009

Solitary brain metastasis as first manifestation of small-cell parotid gland carcinoma with high sensitivity to temozolomide therapy on basis of tumor O6-methylguanine-DNA-methyltransferase expression

artículo científico publicado en 2013

Targeted therapy in brain metastasis

artículo científico publicado en 2012

Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study

artículo científico publicado en 2015

Treatment of brain metastasis: current status and future directions

artículo científico publicado en 2016

Lista de obras de

Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas

Antiangiogenic therapy of brain tumors: the role of bevacizumab.

Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds

Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology).

Brain metastases: current management and new developments

Caveolin 1 expression independently predicts shorter survival in oligodendrogliomas

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.

Controversies in management of low-grade gliomas in light of new data from clinical trials

Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016

Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).

Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology

Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES)

Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016

Ependymomas of the adult: molecular biology and treatment

Ependymomas, neuronal and mixed neuronal-glial tumors, dysembroblastic neuroepithelial tumors, pleomorphic xanthoastrocytomas, and pilocytic astrocytomas

Epilepsy and brain tumors

European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma.

Evaluation of low-grade glioma structural changes after chemotherapy using DTI-based histogram analysis and functional diffusion maps

Gliomatosis cerebri: a review

Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination

Is there a Role for Bevacizumab in Non-Glial Tumors?

Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas.

Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma.

Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study.

Leptomeningeal metastases: a RANO proposal for response criteria.

Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials

Liquoral liquid biopsy in neoplastic meningitis enables molecular diagnosis and mutation tracking: a proof of concept.

MGMT promoter methylation in plasma of glioma patients receiving temozolomide

Malignant spinal cord compression in cerebral glioblastoma multiforme: a multicenter case series and review of the literature

Meningeal carcinomatosis underdiagnosis and overestimation: incidence in a large consecutive and unselected population of breast cancer patients

Meningiomas after cranial radiotherapy for childhood cancer: a single institution experience

Molecularly based management of gliomas in clinical practice

Neuro-oncology: new insights and advances in treatment

Neurologic complications of chemotherapy and other newer and experimental approaches

New developments in the treatment of malignant gliomas

Pharmacologic therapies for malignant glioma: a guide for clinicians.

Point/Counterpoint: Is stereotactic radiosurgery needed following resection of brain metastasis?

Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).

Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.

Rare glial tumors

Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study

Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study

Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments

Skin metastases of glioblastoma in the absence of intracranial progression are associated with a shift towards a mesenchymal immunophenotype: report of two cases

Solitary brain metastasis as first manifestation of small-cell parotid gland carcinoma with high sensitivity to temozolomide therapy on basis of tumor O6-methylguanine-DNA-methyltransferase expression

Targeted therapy in brain metastasis

Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study

Treatment of brain metastasis: current status and future directions